Calming
OTC Healthcare > Calming and sleeping products

Calming And Sleeping Products in Germany

Germany

Euromonitor International's Calming And Sleeping Products in Germany market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.

Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.

Tables: 43  |  Publication date: Apr 2009
Cost: 
GBP560.00

Why buy this report

  • Get insight into trends in market performance
  • Pinpoint growth sectors and identify factors driving change
  • Identify market and brand leaders and understand the competitive environment

Table of contents

OTC HEALTHCARE IN GERMANY : MARKET INSIGHT

EXECUTIVE SUMMARY

OTC healthcare – a stagnating market

Smoking ban drives NRT sales

Changing distribution system

Major brands gaining importance

Mixed outlook for OTC healthcare

KEY TRENDS AND DEVELOPMENTS

Economy stalls, no recovery expected over the medium term

The decline and ageing of Germany’s population continues

Germany’s changing OTC retail environment

Homeopathy gaining ground against herbal products

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008

Table 2 Life Expectancy at Birth 2003-2008

MARKET DATA

Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008

Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008

Table 5 OTC Healthcare Company Shares by Value 2004-2008

Table 6 OTC Healthcare Brand Shares by Value 2005-2008

Table 7 Penetration of Private Label by Sector 2003-2008

Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008

Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008

Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013

Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013

APPENDIX

OTC Registration and Classification

Vitamins & Dietary Supplements Registration and Classification

EU Legislation

Self-medication and Preventative Medicine

Generics

Summary 1 OTC Healthcare Switches 2005-2007

DEFINITIONS

Summary 2 Research Sources

LOCAL COMPANY PROFILES - GERMANY

BEIERSDORF AG - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 3 Beiersdorf AG: Key Facts

Summary 4 Beiersdorf AG: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 5 Beiersdorf AG: Competitive Position 2008

BAYER VITAL GMBH - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 6 Bayer Vital AG: Key Facts

Summary 7 Bayer Vital AG: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

Summary 8 Bayer Vital AG: Production Statistics 2007

COMPETITIVE POSITIONING

Summary 9 Bayer Vital AG: Competitive Position 2008

BOEHRINGER INGELHEIM PHARMA GMBH & CO KG - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 10 Boehringer Ingelheim Pharma GmbH & Co KG: Key Facts

Summary 11 Boehringer Ingelheim Pharma GmbH & Co KG: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 12 Boehringer Ingelheim Pharma GmbH & Co KG: Competitive Position 2008

JOHNSON & JOHNSON GMBH - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 13 Johnson & Johnson GmbH: Key Facts

Summary 14 Johnson & Johnson GmbH: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 15 Johnson & Johnson GmbH: Competitive Position 2008

MCM KLOSTERFRAU VERTRIEBSGESELLSCHAFT MBH - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 16 MCM Klosterfrau Vertriebsgesellschaft mbH: Key Facts

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 17 MCM Klosterfrau Vertriebsgesellschaft mbH: Competitive Position 2008

NOVARTIS AG - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Table 12 Novartis Consumer Health GmbH: Key Facts

Summary 18 Novartis Consumer Health GmbH: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 19 Novartis Consumer Health GmbH: Competitive Position 2008

RATIOPHARM GMBH & CO - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 20 Ratiopharm GmbH & Co: Key Facts

Summary 21 Ratiopharm GmbH & Co: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 22 Ratiopharm GmbH & Co: Competitive Position 2008

STADA ARZNEIMITTEL AG - OTC HEALTHCARE - GERMANY

STRATEGIC DIRECTION

KEY FACTS

Summary 23 STADA Arzneimittel AG: Key Facts

Summary 24 STADA Arzneimittel AG: Operational Indicators

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Summary 25 STADA Arzneimittel AG: Competitive Position 2008

CALMING AND SLEEPING PRODUCTS IN GERMANY

TRENDS

SECTOR DATA

Table 13 Sales of Calming and Sleeping Products: Value 2003-2008

Table 14 Sales of Calming and Sleeping Products: % Value Growth 2003-2008

Table 15 Calming and Sleeping Products Company Shares by Value 2004-2008

Table 16 Calming and Sleeping Products Brand Shares by Value 2005-2008

Table 17 Forecast Sales of Calming and Sleeping Products: Value 2008-2013

Table 18 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013

Change currency displayed
all prices excluding P&P
request more information

Available formats

  • Instant online access
  • Download PDF
  • Download Word document
research methodology

Get Acrobat Reader

click here to download Adobe Acrobat Reader 7.0

© Euromonitor International 2009